EFFICACY AND SAFETY OF LIPID-LOWERING DRUGS IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES IN THE ELDERLY
Effect of hyperlipidemia on morbidity and mortality in elderly patients is considered. Authors also cover issues of efficacy and safety of lipid-lowering therapy in primary and secondary prevention of cardiovascular diseases in patients ≥80 years of age who are the most quickly growing group of popu...
Saved in:
Main Authors: | E. A. Ushkalova, O. N. Tkacheva, N. K. Runikhina, N. A. Chukhareva, A. Yu. Bevz |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2016-06-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/1281 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Economic losses due to low coverage of lipid-lowering therapy in patients with cardiovascular diseases in the Russian Federation
by: Yu. A. Balanova, et al.
Published: (2018-11-01) -
Cardiovascular disease and compliance with lipid-lowering therapy among young individuals with familial hypercholesterolemia in Norway – A register study
by: Gisle Langslet, et al.
Published: (2025-09-01) -
PHARMACOTHERAPY OF ARTERIAL HYPERTENSION IN ELDERLY PATIENTS: FOCUS ON OCTOGENARIANS
by: E. A. Ushkalova, et al.
Published: (2016-05-01) -
EXPERIENCE WITH THE USE OF EVOLOCUMAB THERAPY IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (IN KARELIA REPUBLIC)
by: V. A. Korneva, et al.
Published: (2020-06-01) -
Features of pharmacotherapy in the elderly patients. Introduction to the problem
by: E. A. Ushkalova, et al.
Published: (2016-03-01)